Beijing Konruns Pharmaceutical Co Ltd
SSE:603590
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Beijing Konruns Pharmaceutical Co Ltd
SSE:603590
|
CN |
|
Fuda Alloy Materials Co Ltd
SSE:603045
|
CN |
|
Cyberecord Inc
OTC:CYRD
|
US |
|
S
|
Semk Holdings International Ltd
HKEX:2250
|
HK |
|
First Service Holding Ltd
HKEX:2107
|
CN |
|
Osisko Development Corp
XTSX:ODV
|
CA |
|
Cellnex Telecom SA
MAD:CLNX
|
ES |
|
COG Financial Services Ltd
ASX:COG
|
AU |
|
BNK Financial Group Inc
KRX:138930
|
KR |
Wall Street
Price Targets
Price Targets Summary
Beijing Konruns Pharmaceutical Co Ltd
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Beijing Konruns Pharmaceutical Co Ltd's stock price target?
Not Available
Beijing Konruns Pharmaceutical Co Ltd doesn't have any price targets made by Wall Street professionals.
What is Beijing Konruns Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
16%
For the last 8 years the
compound annual growth rate for
Beijing Konruns Pharmaceutical Co Ltd's revenue is
11%.
The projected
CAGR
for the next 3 years is
16%.
What is Beijing Konruns Pharmaceutical Co Ltd's Operating Income forecast?
Projected CAGR
36%
For the last 8 years the
compound annual growth rate for
Beijing Konruns Pharmaceutical Co Ltd's operating income is
-4%.
The projected
CAGR
for the next 3 years is
36%.
What is Beijing Konruns Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
81%
For the last 8 years the
compound annual growth rate for
Beijing Konruns Pharmaceutical Co Ltd's net income is
-17%.
The projected
CAGR
for the next 3 years is
81%.
